Clinical trial
Perennial Allergic Rhinitis Study In Pediatric Subjects
NCT00108914 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00108914 |
|---|---|
| Title | Perennial Allergic Rhinitis Study In Pediatric Subjects |
| Official title | A Two Week Randomized, Double Blind Placebo Controlled, Parallel Group Study of GW685698X Aqueous Nasal Spray 100mcg and 50mcg QD in Pediatric Subjects With Perennial Allergic Rhinitis |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Perennial |
| Intervention type | Drug |
| Interventions | GW685698X |
| Enrollment | 558 |
| Start date | Feb 1, 2005 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Apr 21, 2005 |
| Last update posted | Jan 19, 2017 |
| Countries | Argentina, Chile, Finland, Italy, Mexico, Slovakia, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: